| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 9 |
| 1 | PREDNISOLONE | 9 |
| 2 | PREDNISOLONE ORAL | 9 |
| 3 | PREDNISOLONE ORAL SOLUTION | 9 |
| 4 | DENOSUMAB | 6 |
| 5 | METHOTREXATE | 6 |
| 6 | RAMIPRIL | 6 |
| 7 | TOCILIZUMAB | 6 |
| 8 | BISOPROLOL FUMARATE | 5 |
| 9 | ADALIMUMAB | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LEVONORGESTREL / ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | 1 | 0.0043 |
| 1 | PYRIDOSTIGMINE BROMIDE ORAL | 1 | 0.0003 |
| 2 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0003 |
| 3 | RADIUM RA 223 DICHLORIDE | 1 | 0.0002 |
| 4 | TEPROTUMUMAB | 1 | 0.0002 |
| 5 | SOTATERCEPT-CSRK | 1 | 0.0002 |
| 6 | PEGASPARGASE | 2 | 0.0002 |
| 7 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0001 |
| 8 | MOXIFLOXACIN HYDROCHLORIDE | 3 | 0.0001 |
| 9 | METHIMAZOLE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 1 | Asparagine-specific Enzyme [EPC] | 2 | 0.0001 |
| 2 | Phenylalanine Metabolizing Enzyme [EPC] | 1 | 0.0001 |
| 3 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 4 | RNA Synthetase Inhibitor Antibacterial [EPC] | 1 | 0.0001 |
| 5 | Angiotensin Converting Enzyme Inhibitor [EPC] | 6 | 0.0000 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 6 | 0.0000 |
| 7 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 8 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 9 | Parathyroid Hormone-Related Peptide Analog [EPC] | 1 | 0.0000 |